ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
395 hedge funds and large institutions have $13.6B invested in Intra-Cellular Therapies Inc. in 2025 Q1 according to their latest regulatory filings, with 159 funds opening new positions, 88 increasing their positions, 118 reducing their positions, and 149 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
7% more first-time investments, than exits
New positions opened: 159 | Existing positions closed: 149
25% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 118
Holders
395
Holding in Top 10
52
Calls
$367M
Puts
$284M
Top Buyers
| 1 | +$647M | |
| 2 | +$546M | |
| 3 | +$434M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$383M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$381M |
Top Sellers
| 1 | -$1.05B | |
| 2 | -$544M | |
| 3 | -$373M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$302M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$271M |